Compare SRRK & EPRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SRRK | EPRT |
|---|---|---|
| Founded | 2012 | 2016 |
| Country | United States | United States |
| Employees | 289 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.8B | 6.6B |
| IPO Year | 2018 | 2018 |
| Metric | SRRK | EPRT |
|---|---|---|
| Price | $56.97 | $31.21 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 12 |
| Target Price | ★ $56.17 | $36.79 |
| AVG Volume (30 Days) | 1.5M | ★ 1.7M |
| Earning Date | 05-07-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 3.98% |
| EPS Growth | N/A | ★ 11.30 |
| EPS | N/A | ★ 0.28 |
| Revenue | N/A | ★ $561,219,000.00 |
| Revenue This Year | N/A | $17.12 |
| Revenue Next Year | $534.24 | $16.27 |
| P/E Ratio | ★ N/A | $111.43 |
| Revenue Growth | N/A | ★ 24.82 |
| 52 Week Low | $27.07 | $28.95 |
| 52 Week High | $58.12 | $34.73 |
| Indicator | SRRK | EPRT |
|---|---|---|
| Relative Strength Index (RSI) | 67.12 | 56.72 |
| Support Level | $41.38 | $29.27 |
| Resistance Level | N/A | $31.43 |
| Average True Range (ATR) | 2.45 | 0.55 |
| MACD | 0.52 | 0.15 |
| Stochastic Oscillator | 85.32 | 77.93 |
Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.
Essential Properties Realty Trust Inc is a real estate investment trust. It is an internally managed real estate company acquires, owns and manages single-tenant properties that are net leased on a long-term basis to middle-market companies operating service-oriented or experience-based businesses. The Company generally invests in and leases freestanding, single-tenant commercial real estate facilities where a tenant services its customers and conducts activities that are essential to the generation of the tenant's sales and profits.